The neuroanatomy and neuroendocrinology of fragile X syndrome

Wiley - Tập 10 Số 1 - Trang 17-24 - 2004
David Hessl1,2, Susan M. Rivera3,2, Allan L. Reiss4
1Department of Psychiatry and Behavioral Sciences, University of California–Davis, Sacramento, California
2M.I.N.D. Institute, University of California, Davis, Sacramento, California
3Department of Psychology, University of California, Davis, Davis, California
4Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California

Tóm tắt

AbstractFragile X syndrome (FXS), caused by a single gene mutation on the X chromosome, offers a unique opportunity for investigation of gene–brain–behavior relationships. Recent advances in molecular genetics, human brain imaging, and behavioral studies have started to unravel the complex pathways leading to the cognitive, psychiatric, and physical features that are unique to this syndrome. In this article, we summarize studies focused on the neuroanatomy and neuroendocrinology of FXS. A review of structural imaging studies of individuals with the full mutation shows that several brain regions are enlarged, including the hippocampus, amygdala, caudate nucleus, and thalamus, even after controlling for overall brain volume. These regions mediate several cognitive and behavioral functions known to be aberrant in FXS such as memory and learning, information and sensory processing, and social and emotional behavior. Two regions, the cerebellar vermis, important for a variety of cognitive tasks and regulation of motor behavior, and the superior temporal gyrus, involved in processing complex auditory stimuli, are reported to be reduced in size relative to controls. Functional imaging, typically limited to females, has emphasized that individuals with FXS do not adequately recruit brain regions that are normally utilized by unaffected individuals to carry out various cognitive tasks, such as arithmetic processing or visual memory tasks. Finally, we review a number of neuroendocrine studies implicating hypothalamic dysfunction in FXS, including abnormal activation of the hypothalamic–pituitary–adrenal (HPA) axis. These studies may help to explain the abnormal stress responses, sleep abnormalities, and physical growth patterns commonly seen in affected individuals. In the future, innovative longitudinal studies to investigate development of neurobiologic and behavioral features over time, and ultimately empirical testing of pharmacological, behavioral, and even molecular genetic interventions using MRI are likely to yield significant positive changes in the lives of persons with FXS, as well as increase our understanding of the development of psychiatric and learning problems in the general population. MRDD Research Reviews 2004;10:17–24. © 2004 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1002/mrdd.1410010407

10.1002/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO;2-B

10.1002/ajmg.b.10035

10.1016/S0006-3223(02)01432-4

10.1002/ajmg.1320020410

10.1002/(SICI)1096-8628(19990402)83:4<327::AID-AJMG19>3.0.CO;2-R

Bregman JD, 1990, Thyroid function in fragile‐X syndrome males, Yale J Biol Med, 63, 293

10.1176/ajp.152.7.973

10.1111/j.1399-0004.1983.tb02231.x

Brunberg JA, 2002, Fragile X premutation carriers: Characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction, Am J Neuroradiol, 23, 1757

10.1002/ajmg.1320310408

10.1007/BF00284767

Coulam CB, 1986, Incidence of premature ovarian failure, Obstet Gynecol, 67, 604

10.1002/ajmg.1320380221

10.1038/ng0893-335

10.1016/0165-0173(90)90012-D

10.1097/00004583-200203000-00002

10.1093/brain/124.8.1610

10.1002/ajmg.1320380409

10.1002/ajmg.1320230116

10.1111/j.1399-0004.1987.tb03155.x

10.1002/ajmg.a.10549

10.1002/1096-8628(20001211)95:4<307::AID-AJMG3>3.0.CO;2-3

10.1212/WNL.57.1.127

10.1159/000067551

10.1016/S0166-2236(96)10069-2

10.1542/peds.108.5.e88

10.1016/S0306-4530(01)00087-7

10.1002/ajmg.1320410306

10.1016/0006-8993(86)90815-2

10.1002/ajmg.a.10862

10.1093/cercor/10.10.1038

10.1006/nlme.1999.3914

10.1086/374321

10.1172/JCI119538

10.1016/S0925-4927(97)00019-X

10.1016/S1083-3188(96)70031-1

10.1176/appi.ajp.158.7.1040

10.1002/ajmg.1320580311

10.1007/s00439-003-0939-z

10.1037/0894-4105.9.4.470

10.1023/A:1025857422026

10.1097/00004703-199310000-00007

10.1136/jmg.20.3.169

10.1016/S0165-0173(96)00012-4

10.1152/physrev.1986.66.4.1121

McEwen BS, 1992, The vulnerability of the hippocampus to protective and destructive effects of glucocorticoids in relation to stress, Br J Psychiat, 15, 18, 10.1192/S0007125000296645

10.1016/S0896-6273(03)00034-5

10.1002/ajmg.1320370221

10.1007/s004150200040

10.1212/WNL.50.1.121

10.1093/humrep/14.5.1217

10.1016/S0306-4522(99)00285-7

10.1002/ajmg.1320170111

10.1038/nm0295-159

10.1002/ana.410290107

Reiss AL, 1991, Neuroanatomy in fragile X females: the posterior fossa, Am J Hum Genet, 49, 279

10.1212/WNL.44.7.1317

10.1002/ajmg.1320310220

10.1002/hbm.10048

10.1002/ana.410240310

10.1007/BF00687814

10.1001/jama.238.15.1646

10.1001/archpsyc.57.10.925

10.1016/S0022-3956(01)00024-3

10.1002/ajmg.1320510419

10.1002/1096-8628(20010915)103:1<81::AID-AJMG1505>3.0.CO;2-T

10.1093/hmg/6.8.1315

10.1162/089892902317236812

10.1136/jmg.12.4.367

10.1136/jmg.33.7.611

10.1002/(SICI)1096-8628(19990402)83:4<248::AID-AJMG3>3.0.CO;2-1

10.1097/00004703-200008000-00004

10.1002/ajmg.1320380267